Small observational studies have reported altered circulating CXCL12 levels in sepsis and in subgroups of patients with acute lung injury or acute respiratory distress syndrome (ARDS) [96], but these findings are inconsistent—likely reflecting variability in sampling time points (acute versus recovery phase), infection source, patient heterogeneity, and assay methodologies. The gene discussed is CXCL12; the disease is infection.